Sorin Group S.p.A. (SRN) Announces FDA 510(K) Clearance for the New Sorin CONNECT Perfusion Charting System
7/30/2013 9:53:45 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
MILAN--(BUSINESS WIRE)--Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the 510(k) clearance for commercialization of Sorin CONNECTTM, Sorin Group’s new innovative and intuitive perfusion electronic charting system.
Help employers find you! Check out all the jobs and post your resume.
comments powered by